Brief: Elicera Therapeutics Receives Allowance For Chinese Patent

Elicera Therapeutics AB

08/09/2023 09:24

Sept 8 (Reuters) - Elicera Therapeutics AB  ELIC.ST :
    * ELICERA THERAPEUTICS RECEIVES NOTICE OF ALLOWANCE FOR
CHINESE
PATENT PROTECTING THE ITANK PLATFORM
    * ONCE GRANTED, PATENT CAN BE KEPT IN FORCE UNTIL 2036.
    * RECEIVED A SO CALLED "NOTICE OF ALLOWANCE" FROM CHINEASE
PATENT
OFFICE IN ITS PATENT APPLICATION RELATING TO USE OF
ITANK-TECHNOLOGY IN CAR T-CELL THERAPIES

Source text for Eikon:  ID:nWkr3TqyZn 
Further company coverage:  ELIC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))